Head of Hematology Franchise, Pipeline Commercialization Strategy
Posted 4 weeks ago
Interested in this position?
Upload your resume and we'll match you with this and other relevant opportunities.
Upload Your ResumeAbout This Role
This leadership position is responsible for developing key strategies and tactics to accelerate Abbie's leadership in core disease areas within hematological malignancies. The role involves assessing commercial viability of the pipeline, driving strategic value creation across the lifecycle, and overseeing the development of target product profiles.
Responsibilities
- Develop, champion and communicate vision and overall compelling strategy to all related stakeholder groups gaining commitment and support to guide portfolio prioritization, asset strategies and BD investments within hematological malignancies.
- Understand market, key segment value drivers, growth opportunities, target product profiles, product positioning and revenue potential for multiple Phase II+ assets/indications within the heme franchise to drive winning portfolio value proposition plans and strong P&L investment thesis.
- Define and drive strategic value creation across lifecycle together with R&D and commercial cross-functional partners for AbbVie's hematology portfolio, integrating diverse internal and external perspectives.
- Partner with the PCS VP to deliver optimal commercial strategies to maximize the value of each of the assets within the heme franchise, as well as an integrated portfolio approach within the franchise.
- Partner with Medical Affair and Health Impact (MHI), Early & Late Clinical Development, and Commercial Cross-functional leaders to develop scientific platforms and drive data generation to satisfy Global and Area requirements for target product labels and target product claims.
- Oversee development and delivery of the product Target Product Profiles (TPP) within heme franchise.
- Oversee development of business cases for governance endorsement.
- Identify new value generation for the franchise to unlock further opportunity and drive innovative and novel ways to accelerate commercialization and maximize value for patients and the company for the franchise.
- Drive prioritization of key leverage points in the treatment process and develop behavioral objectives for each stakeholder group to define commercial strategy for the assets and for the entire franchise.
- Initiate geo-strategy and indication prioritization within the franchise in partnership with R&D, Commercial cross-functional leaders, and Affiliates on formulating optimal reimbursement and access strategies to fully realize value of multiple assets.
Requirements
- Bachelors degree
- 10-15+ years of experience in the pharmaceutical industry in progressive commercial leadership roles in marketing and/or sales
- Recency of commercial in-line operational experience
- Oncology therapeutic experience
- Demonstrated ability to influence and manage a complex set of internal and external stakeholders
- Strong strategic marketing skills
- Strong financial and commercial acumen
- Strong executive presence and leadership skills
- Demonstrated and consistent experience in successfully leading organizational change
- Outstanding partnering skills and the ability to lead a multi-disciplinary team and drive commercial decisions in a highly matrixed organization
- Proven track record of successful leadership, management and coaching of teams and individuals, and in having developed talent
Qualifications
- Bachelors degree required; advanced degree (MBA, Ph.D, or MD) preferred
- 10-15+ years of experience in the pharmaceutical industry in progressive commercial leadership roles in marketing and/or sales with recency of commercial in-line operational experience.
Nice to Have
- Advanced degree (MBA, Ph.D, or MD)
- P&L ownership in US or other major markets
- Successful launch experience
- Managed care experience
- Experience in Multiple Myeloma
- Global experience
Benefits
About BioSpace
Lilly is a global healthcare leader headquartered in Indianapolis, Indiana, specializing in discovering and bringing life-changing medicines to patients worldwide. They are investing over $1 billion to create a new state-of-the-art manufacturing site in Concord, NC, focusing on parenteral medication...